Tangie Dream is a modern, hybrid-indica strain whose genetic origins are thinly documented and remain a subject of debate. While it counts Copenhagen Kush among its lineage, its full ancestry is not publicly confirmed or clearly defined. Because the breeding history lacks a verified record, details regarding its original development remain unavailable, placing this strain firmly in the category of varieties with largely undocumented genetic backgrounds.

The terpene profile of this strain is complex and multi-faceted, characterized by a confirmed chemical hierarchy beginning with myrcene, followed by terpinolene, caryophyllene, pinene, limonene, beta-pinene, ocimene, humulene, linalool, nerolidol, guaiol, bisabolol, alpha-terpinene, and gamma-terpinene. Regarding its potency, the strain features an estimated THC content of approximately 13.9 percent, while its CBD levels are an estimated 0.02 percent. These chemical constituents contribute to a profile that is likely defined by the interplay between its dominant myrcene-heavy base and the secondary notes provided by terpinolene and caryophyllene.

As a hybrid-indica, Tangie Dream is engineered for a balanced experience that leaves the user feeling relaxed and focused. It is suited for users seeking relief from pain, stress, or sleep-related difficulties. The plant is rated as moderate in difficulty to cultivate and performs well in both indoor and outdoor environments. Growers can expect a high yield from this variety, which reaches maturity after a 55-day flowering period. There are currently no notable offspring recorded for this strain in public registers.